This study will investigate the value and applicability of LC/MS/MS to assess medication use to medication verification and reconciliation in older adults with polypharmacy visiting the ED. Discrepancies between LC/MS/MS and medication verification…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
65-plussers met (verdenking op) polyfarmacie die op de SEH komen voor de interne geneeskunde
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The aim of this study is to explore the value and applicability of LC/MS/MS
analysis in older adults with (suspected) polypharmacy at the ED. We will
determine the agreement between the LC/MS/MS and the results of the medication
verification team in older adults visiting the ED with (suspected)
polypharmacy. Reasons for discrepancies will be explored. Furthermore we will
retrospectively determine the impact the LC/MS/MS results could have had on the
diagnostic process and treatment policy.
Secondary outcome
Estimation of patient groups with a high risk of medication discrepencies (with
potential relevant impact on diagnostic process and treatment policy).
Background summary
One in four older adults is prescribed more than five medications (1, 2). In
the emergency department setting, this percentage increases up to 61% (3).
However, actual medication use among older adults presenting at the ED is often
unclear, including prescribed, over-the-counter, and recreational drug use (4,
5). Even if complete prescription lists are available, this does not prove the
actual intake of medication as non-compliance occurs in almost 50% of older
adults with chronic illnesses (5-7). To tackle this problem, current policy
consists of medication verification and reconciliation by a physician or
pharmacist (8). Results of this analysis are at risk of being incomplete due to
inaccuracy of patient recall and incomplete or delayed access to pharmacy
records (9). In patients with cognitive deficits or loss of con-sciousness,
medication verification is even more challenging and merely based on recent
pharmacist give-outs and caretaker*s knowledge, if available (10). Unclear
medication use may lead to errors in medication prescription by doctors, which
could decrease the effective-ness of treatment and cause serious harm (11, 12).
One in seven ED visits of older adults are medication related, of which
three-quarters are preventable due to underuse, noncompliance or adverse drug
events (13). Consequences we hypothesize could partially be prevented if
doctors had a more accurate display of the patient*s actual medication use.
Currently, the ED does not use pharmacological analysis techniques, like the
liquid chromatography tandem mass spectrometry (LC/MS/MS), to assess medication
use. This technique is mainly used in toxicology, endocrine system, proteins
and newborn screening (14). For an ED, it has mainly been applied to determine
the detect recreational drugs in pa-tients presenting with intoxication (15).
Additionally, the LC/MS/MS could be used to deter-mine medications in patients*
blood (14). A previous study with LC/MS/MS demonstrated that 63.0% of patients
have a discrepancy between the actual intake and the medication verifica-tion.
They found that opioids and diazepam were the most common medications detected
in the blood without prescription (16). This extra information could provide
more insights into patients* compliance and optimize the diagnostic process and
treatment policy, beyond the standard care practice of medication
verification.
Study objective
This study will investigate the value and applicability of LC/MS/MS to assess
medication use to medication verification and reconciliation in older adults
with polypharmacy visiting the ED. Discrepancies between LC/MS/MS and
medication verification and reconciliation will be described and analysed
including the potential impact it could have had on the diagnostic process and
treatment policy. We hypothesize that LC/MS/MS will provide additional insights
to the medication verification and reconciliation which will alter the
treatment policy.
Study design
This observational study will be conducted in the ED of Amsterdam UMC, location
AMC. During the study, a questionnaire concerning demographic characteristics
and medication use will be conducted at baseline by the researcher at the ED
with the patient or their caretaker/family. One blood sample will be taken,
either by intravenous cannula or a venepuncture, and collected in a 6 ml EDTA
tube. Blood samples will be analysed at a later stage as the LC/MS/MS is
located at the Clinical Pharmaceutical and Toxicology laboratory at OLVG,
location West. The value of the results of the LC/MS/MS to the medication will
be determined retrospectively by a five point scale for the diagnostic process
and treatment policy by the research team. After the analysis, patients might
be contacted by phone if additional questions arise regarding medication use
due to the results.
Study burden and risks
There are risks associated with venipuncture. There is a risk of pain,
haematoma formation and vasovagal reaction. There is also a risk of needlestick
injury, where a person comes into contact with another person's blood or body
fluids. Contamination is dangerous for disease carriers, but also for those
being cared for, such as patients. The chances of this happening during a
venipuncture are very low.
Venipuncture is avoided as much as possible by using a venipuncture in the
first place. If a venipuncture is needed, the chances of complications are low.
Venipunctures are carried out by trained healthcare professionals where
venipunctures are part of routine care.
De Boelelaan 1117
Amsterdam 1081 HV
NL
De Boelelaan 1117
Amsterdam 1081 HV
NL
Listed location countries
Age
Inclusion criteria
• Patient is 65 years or older.
• Patient visits the emergency department of Amsterdam UMC, location AMC, for
the internal medicine specialty or for another medicine specialty but is
subsequentially admitted for the internal medicine specialty.and is then
subsequentially admitted for the internal medicine specialty.
• Patients use five or more prescribed medications, or are suspected of using
five or more prescribed medications as determined by the treating physician at
the emergency department. The medications must have a systemic effect, with at
least 10% availability in the systemic circulation. Supplements are excluded.
• Competent individuals can only participate if they wish to be informed about
incidental relevant findings regarding their health from the analysis.
Exclusion criteria
Patients are excluded if no medication verification was performed by the
pharmacy team due to reasons such as personnel shortage. Note: patients are
eligible for inclusion if medication verification could not be performed
because the patient or representatives were not available at time of admission,
i.e. due to severe illness, confusion etc.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL86797.018.24 |